Join BOPA
Back to news articles

FRCR Examination Board

By BOPA Committee on 20th April 2022

FRCR Examination Board

RCR are currently recruiting several posts for the board: Oncologists and specialist examiners in Medical Statistics, Clinical Pharmacology, Cancer Biology and Radio Biology. All relevant information (role description and link to apply can be found here: https://www.rcr.ac.uk/college/get-involved/become-examiner

If any BOPA member is interested in any of the vacancies, please see more information via the link above.

Please remember that the closing date for receipt of applications is 14 May 2022

Latest News

By BOPA Executive Committee on 1st August 2026

4 Weeks left to Nominate your BOPA Fellowship

4 Weeks left to nominate a BOPA Fellow for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Executive Committee on 31st July 2026

Supporting awareness of occupational risks from hazardous medicinal products – BOPA and PASG

Dear BOPA Member, Every day, oncology pharmacy professionals play a vital role in ensuring patients receive safe and effective SACT. Whether preparing, dispensing, transporting or supporting the administration of hazardous…

Read article
By BOPA Executive Committee on 29th July 2026

Publication ALERT – Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation

BOPA Publication: Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation – Annette (Netty) Cracknell, Dharmisha Chauhan, Lisa Barrott, Emma…

Read article
By BOPA on 24th July 2026

Call for BOPA Award nominations – 1 week left!

It’s awards time – call for nominations! We have had lots of positive feedback from the introduction of the awards dinner at the annual conference, and we are now calling…

Read article